Hepatitis C Treatment Response in Liver Transplant Recipients
β Scribed by Wijeratne, Ranjith; Dworetzky, Joshua; Thomas, Alice; Sahota, Amandeep; Sheinbaum, Alan J.
- Book ID
- 123539926
- Publisher
- Elsevier Science
- Year
- 2011
- Tongue
- English
- Weight
- 84 KB
- Volume
- 9
- Category
- Article
- ISSN
- 1542-3565
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Recurrent hepatitis C after liver transplantation is a universal phenomenon. Graft reinfection occurs rapidly; once it is established, allograft cirrhosis and decompensation rapidly ensue in many patients. Treatment with pegylated interferon plus ribavirin is the standard of care among nontransplant
Hepatitis C recurrence after liver transplantation is a serious problem, leading to increased graft loss and morbidity in some individuals. Treatment with interferon and other agents is controversial and not highly efficacious. The use of an effective antiviral agent to reduce or eliminate viral bur